Equities research analysts expect that Safeguard Scientifics, Inc (NYSE:SFE) will post earnings per share (EPS) of ($0.85) for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics reported earnings of ($1.21) per share in the same quarter last year, which would suggest a positive year over year growth rate of 29.8%. The business is scheduled to announce its next earnings results on Thursday, July 25th.
According to Zacks, analysts expect that Safeguard Scientifics will report full year earnings of ($1.00) per share for the current year. For the next financial year, analysts expect that the firm will report earnings of ($1.70) per share. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for Safeguard Scientifics.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings results on Thursday, May 2nd. The asset manager reported $1.05 EPS for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.25.
NYSE:SFE traded up $0.07 on Tuesday, reaching $11.57. The stock had a trading volume of 1,748 shares, compared to its average volume of 71,946. Safeguard Scientifics has a 1-year low of $7.98 and a 1-year high of $13.60. The company has a quick ratio of 1.48, a current ratio of 1.06 and a debt-to-equity ratio of 0.03. The firm has a market cap of $238.08 million, a PE ratio of -15.22 and a beta of 1.06.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Yakira Capital Management Inc. lifted its holdings in shares of Safeguard Scientifics by 2.7% in the 1st quarter. Yakira Capital Management Inc. now owns 818,289 shares of the asset manager’s stock worth $8,878,000 after buying an additional 21,600 shares during the period. Salzhauer Michael increased its holdings in shares of Safeguard Scientifics by 29.1% in the first quarter. Salzhauer Michael now owns 20,405 shares of the asset manager’s stock valued at $221,000 after purchasing an additional 4,600 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Safeguard Scientifics by 18.7% in the first quarter. Wells Fargo & Company MN now owns 24,485 shares of the asset manager’s stock valued at $265,000 after purchasing an additional 3,851 shares during the period. Parametric Portfolio Associates LLC increased its holdings in shares of Safeguard Scientifics by 409.7% in the first quarter. Parametric Portfolio Associates LLC now owns 99,391 shares of the asset manager’s stock valued at $1,078,000 after purchasing an additional 79,892 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in shares of Safeguard Scientifics by 118.1% in the first quarter. JPMorgan Chase & Co. now owns 12,052 shares of the asset manager’s stock valued at $131,000 after purchasing an additional 6,525 shares during the period. Institutional investors own 69.66% of the company’s stock.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Story: Short Selling – Explanation For Shorting Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.